Sep 10, 2026 08:00AM
Aug 4, 2026 08:00AM
Aug 3, 2026 08:00AM
Aug 3, 2026 08:00AM
Jun 4, 2026 08:00AM
May 19, 2026 08:01AM
May 19, 2026 08:00AM Lipocine Announces LPCN 1154 Phase 3 Data Accepted for Oral Presentation at 2026 ASCP Annual Meeting
May 19, 2026 04:00AM
May 18, 2026 08:00AM
May 7, 2026 04:05PM
Apr 2, 2026 08:02AM
Apr 2, 2026 08:00AM
Mar 10, 2026 08:00AM
Feb 18, 2026 08:01AM Lipocine completes patient enrollment in phase 3 postpartum depression trial
Feb 18, 2026 08:00AM
Jan 20, 2026 08:01AM
Jan 20, 2026 08:00AM
Jan 19, 2026 12:20PM
Jan 12, 2026 08:01AM
Jan 12, 2026 08:00AM
Dec 16, 2025 08:00AM Lipocine reaches 80% enrollment in postpartum depression drug trial
Dec 16, 2025 08:00AM
Nov 18, 2025 08:01AM
Nov 18, 2025 08:00AM
Nov 6, 2025 08:00AM
Nov 4, 2025 08:00AM
Sep 30, 2025 08:01AM
Sep 30, 2025 08:00AM Lipocine Provides Progress Update on LPCN 1154 Phase 3 Clinical Trial in Postpartum Depression (PPD)
Sep 5, 2025 04:30PM
Aug 26, 2025 08:00AM
Aug 5, 2025 08:00AM
Jun 30, 2025 06:53AM
Jun 26, 2025 08:04AM
Jun 26, 2025 08:00AM
Jun 23, 2025 08:00AM Lipocine to Host Virtual R&D Investor Event to Discuss LPCN 1154 (BRLIZIO™) as a Treatment for Postpartum Depression on July 9, 2025
Jun 10, 2025 06:41AM
Jun 9, 2025 08:02AM
Jun 9, 2025 08:00AM
May 22, 2025 08:00AM
May 14, 2025 08:00AM
May 8, 2025 08:00AM
May 6, 2025 08:07AM Lipocine (LPCN) Announces License and Supply Agreement for TLANDO in Brazil
May 6, 2025 08:00AM
Mar 26, 2025 08:00AM
Mar 13, 2025 08:00AM
Mar 12, 2025 08:00AM
Feb 6, 2025 08:03AM
Feb 6, 2025 08:00AM
Dec 17, 2024 08:01AM Lipocine (LPCN) Granted FDA Fast Track Designation for LPCN 1148
Dec 17, 2024 08:00AM

330,719 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All